Restricted Albumin Utilization Is Safe and Cost-effective in Pediatric Cardiac Surgery Intensive Care Unit | ||||
Cardiovascular Research Prove Journal | ||||
Volume 8, Issue 2, December 2024 PDF (1.24 MB) | ||||
Document Type: Abstracts | ||||
DOI: 10.21608/cvrepj.2024.400097 | ||||
![]() | ||||
Abstract | ||||
Volume expansion is often necessary after cardiac surgery, and albumin is often administered. Albumin has been used for fluid resuscitation in the OR and ICU, since 1940 (Rabin, Joseph2018) Its usage gained prominence based on the classic descriptions of trans vascular exchange by Earnest Starling who purported that colloids such as albumin should be more effective at increasing depleted intravascular volume due to their relative vascular membrane impermeability when compared to crystalloids such as saline. In the pediatric cardiac intensive care unit (PCICU) at Aswan Heart Centre, there were albumin usage is high without restriction, in addition to financial effect because the price of albumin vials has increased because of global economic changes. so, cost cost-effectiveness quality improvement project was started, and applying restrictive guidelines from the last two weeks of June 2022 | ||||
Statistics Article View: 102 PDF Download: 54 |
||||